Page last updated: 2024-08-25

1-ethyl-2-benzimidazolinone and ns 1619

1-ethyl-2-benzimidazolinone has been researched along with ns 1619 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brady, G; Edwards, G; Feletou, M; Gardener, MJ; Vanhoutte, PM; Weston, AH1
Van de Voorde, J; Vanheel, B1
Cao, Y; Dreixler, JC; Houamed, KM; Roberts, MT; Roizen, JD1
Bang, H; Kim, K; Kim, T; Ko, JH; Lee, W; Lim, I; Noh, YH; Park, H; Shin, J; Song, JH; Yun, J1
Endemann, DH; Resch, M; Riegger, GA; Schach, C; Schmid, PM1

Other Studies

5 other study(ies) available for 1-ethyl-2-benzimidazolinone and ns 1619

ArticleYear
Further investigation of endothelium-derived hyperpolarizing factor (EDHF) in rat hepatic artery: studies using 1-EBIO and ouabain.
    British journal of pharmacology, 1999, Volume: 128, Issue:5

    Topics: Acetylcholine; Animals; Benzimidazoles; Biological Factors; Calcium Channel Agonists; Cromakalim; Electrophysiology; Endothelium, Vascular; Enzyme Inhibitors; Hepatic Artery; In Vitro Techniques; Male; Microelectrodes; Muscle, Smooth, Vascular; Ouabain; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Vasodilator Agents

1999
EDHF-mediated relaxation in rat gastric small arteries: influence of ouabain/Ba2+ and relation to potassium ions.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:4

    Topics: Animals; Arteries; Barium; Benzimidazoles; Biological Factors; Calcium Channel Agonists; Cardiotonic Agents; Drug Interactions; Female; In Vitro Techniques; Membrane Potentials; Ouabain; Potassium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Stomach; Vasodilation

2000
Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:3

    Topics: Benzimidazoles; Calcium Channel Agonists; Cells, Cultured; Chlorzoxazone; Electrophysiology; Humans; Muscle Relaxants, Central; Potassium Channels; Potassium Channels, Calcium-Activated; Recombinant Proteins; Small-Conductance Calcium-Activated Potassium Channels; Structure-Activity Relationship; Zoxazolamine

2001
Expression of Ca2+ -activated K+ channels in human dermal fibroblasts and their roles in apoptosis.
    Skin pharmacology and physiology, 2010, Volume: 23, Issue:2

    Topics: Adult; Apoptosis; Benzimidazoles; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Gene Expression; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Membrane Potential, Mitochondrial; Skin; Small-Conductance Calcium-Activated Potassium Channels; Young Adult

2010
Type 2 diabetes: increased expression and contribution of IKCa channels to vasodilation in small mesenteric arteries of ZDF rats.
    American journal of physiology. Heart and circulatory physiology, 2014, Oct-15, Volume: 307, Issue:8

    Topics: Acetylcholine; Animals; Apamin; Benzimidazoles; Calcium Channel Agonists; Charybdotoxin; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Endothelium, Vascular; Heterozygote; Homozygote; Intermediate-Conductance Calcium-Activated Potassium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mesenteric Arteries; Nitric Oxide Synthase Type III; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Zucker; RNA, Messenger; Small-Conductance Calcium-Activated Potassium Channels; Vasodilation

2014